Submitted:
24 October 2023
Posted:
26 October 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Materials
2.2. Apparatus and Operations
2.3. Measurement Procedures
2.4. Preparation of Reference Solution and Sample Solution
2.4.1. Preparation of Residual Solvent Localization Solution
2.4.2. Preparation of Reference Solution
2.4.3. Preparation of Sample Solution
2.5. Method Validation
3. Results and Discussion
3.1. Optimization of Chromatographic Conditions
3.1.1. The Effect of Column Temperature
3.1.2. The Effect of Equilibrium Time
3.2. Method Validation
3.2.1. System Suitability
3.2.2. Repeatability Test
3.2.3. Linearity
3.2.4. Detection (LOD) and Quantitation (LOQ) Limits
3.2.5. Accuracy
3.2.6. Durability
4. Conclusions
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Gu, H.Z. The clinical application of ursodeoxycholic acid. Inn. Mong. Tradit. Chin. Med. 2012, 2, 52–53. [Google Scholar]
- Qi, Z.; Xu, M. L.; Zheng, Y.Y. Clinical use and research progress of ursodeoxycholic acid. J. Clin. Ration. Drug Use 2016, 9, 84–85. [Google Scholar]
- Wan, J.F.; Chu, S.F.; Zhou, X.; Li, Y.T.; He, W.B.; Tan, F.; Luo, P.; Ai, Q.D.; Wang, Q.; Chen, N.N. Ursodeoxycholic acid protects interstitial Cajal-like cells in the gallbladder from undergoing apoptosis by inhibiting TNF-α expression. Acta Pharmacol Sin 2018, 39, 1493–1500. [Google Scholar] [CrossRef] [PubMed]
- Gazda, J.; Drazilova, S.; Gazda, M.; Martin Janicko, M.; Koky, T.; Macej, M.; Carbone, M.; Jarcuska, P. Treatment response to ursodeoxycholic acid in primary biliary cholangitis: A systematic review and meta-analysis. Dig. Liver Dis. 2023, 55, 1318–1327. [Google Scholar] [CrossRef] [PubMed]
- National Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China: Part II. China Medical Science and Technology Press, China, 2020.
- United States Pharmacopoeia Commission. Ursodeoxycholic acid, US Pharmacopoeia: USP43, 2020.
- European Pharmacopoeia Commission, Ursodeoxycholic acid, European Pharmacopoeia: EP10.0, 2020.
- Dawkins, M. S. From an animal's point of view: motivation, fitness, and animal welfare. Behav. Brain Sci. 1990, 13, 1–9. [Google Scholar] [CrossRef]
- Kim, O.Y.; Lee, S.Y.; Lee, D.Y.; Hur, S.J. Developing a procedure to extract chenodeoxycholic acid and synthesize ursodeoxycholic acid from pig by-products. Heliyon 2023, 9, e18313. [Google Scholar] [CrossRef] [PubMed]
- Lu, M. F.; Yin, W. C.; Wang, F. D.; Peng, D.M. Improvement of the synthesis process of ursodeoxycholic acid. Chin. J. Pharm. Ind. 2015, 46, 1058–1059. [Google Scholar]
- Chen, W.; Hu, D.; Feng, Z.; Liu, Z. An effective synthesis of ursodeoxycholic acid from dehydroepiandrosterone. Steroids 2021, 172, 108870. [Google Scholar] [CrossRef] [PubMed]
- Shen, J. X.; Dong, D. D.; Wang, Z. F.; Wan, J. F.; Cao, X. J. Synthesis of ursodeoxycholic acid by electrochemical stereoselective reduction of 7-ketolithocholic acid in aprotic solvents. Sci. Rep. 2021, 1, 16273–16273. [Google Scholar] [CrossRef] [PubMed]
- Fu, D.W.; Fu, J.J.; Li, J.J.; Tang, Y.; Shao, Z.W.; Zhou, D.Y.; Song, L. Efficient encapsulation of curcumin into spent brewer’s yeast using a pH-driven method. Food Chem. 2022, 394, 133537. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.H. Construction and application of a recombinant yeast strain for efficient synthesis of ursodeoxycholic acid. Tianjin: Tianjin University of Science and Technology, 2022.
- Yang, B.Y.; You, Z.N.; Xue, J.T.; Pan, J.; Li, C.X.; Xu, J.H. Clean enzymatic production of ursodeoxycholic acid enabled by a newly identified NADH- dependent 7β-hydroxysteroid dehydrogenase. Mol. Catal. 2023, 537, 112946. [Google Scholar] [CrossRef]
- Zhang, C.L; Li, C.S.; Yu, X.L. Progress in Chinese patents for the effective ingredient ursodeoxycholic acid in bear bile. Chin. J. Tradit. Chin. Med. 2012, 37, 2851–2854. [Google Scholar]
- Luo, L.L.; Yu, J.; Wei, H.Q.; Hou, W.B.; Li, W.L. Research progress in the synthesis of ursodeoxycholic acid. Synth. Chem. 2021, 29, 986–996. [Google Scholar]
- Li, J.; Li, X.; Wang, F.; et al. Determination of three residual organic solvents in ursodeoxycholic acid by headspace gas chromatography. Prog. Mod. Biomed. Sci. 2015, 31, 6156–6159. [Google Scholar]
- Zhou, H. J. International Technical Requirements for Drug Registration Q3C. Beijing: People's Health Publishing House, 2000, 1-8.
- State Food and Drug Administration. Technical guidelines for the study of residual solvents in chemical drugs. 2005, 6-7.

| Column temperature | Test samples | ||||
|---|---|---|---|---|---|
| Unknown peak (2.758min) | Acetone | Tert butanol | Triethylamine | ||
| 60 °C | Rt (min) | 2.758 | 3.646 | 3.948 | 6.218 |
| Resolution | —— | 5.709 | 2.191 | 22.044 | |
| Peak area | 45.542 | 411.721 | 2.783 | 12.881 | |
| Tailing factor | 1.533 | 0.934 | 1.056 | 1.718 | |
| Number of theoretical plates | 4268.713 | 10628.133 | 13918.130 | 119444.528 | |
| 80 °C | Rt (min) | 2.758 | 3.645 | 3.949 | 6.212 |
| Resolution | —— | 5.702 | 2.215 | 22.277 | |
| Peak area | 39.932 | 641.844 | 3.963 | 26.420 | |
| Tailing factor | 1.479 | 1.092 | 0.923 | 1.685 | |
| Number of theoretical plates | 4334.966 | 10402.865 | 14348.943 | 123072.631 | |
| 100 °C | Rt (min) | 2.740 | 3.633 | 3.935 | 6.193 |
| Resolution | —— | 6.345 | 2.283 | 22.551 | |
| Peak area | 3.255 | 712.048 | 9.883 | 36.692 | |
| Tailing factor | 1.349 | 1.145 | 0.985 | 1.500 | |
| Number of theoretical plates | 5707.791 | 11286.903 | 15125.859 | 118511.515 | |
| Equilibrium time | Test samples | ||||
|---|---|---|---|---|---|
| Unknown peak (2.758min) | Acetone | Tert butanol | Triethylamine | ||
| 5min | Rt (min) | 2.742 | 3.633 | 3.934 | 6.191 |
| Resolution | —— | 6.172 | 2.272 | 22.403 | |
| Peak area | 3.988 | 676.439 | 4.905 | 52.018 | |
| Tailing factor | 1.718 | 1.026 | 1.145 | 1.528 | |
| Number of theoretical plates | 5218.119 | 11320.143 | 14921.887 | 116516.392 | |
| 10min | Rt (min) | 2.740 | 3.633 | 3.935 | 6.193 |
| Resolution | —— | 6.345 | 2.283 | 22.551 | |
| Peak area | 3.255 | 712.048 | 9.883 | 36.692 | |
| Tailing factor | 1.349 | 1.145 | 0.985 | 1.500 | |
| Number of theoretical plates | 5707.791 | 11286.903 | 15125.859 | 118511.515 | |
| 20min | Rt (min) | 2.756 | 3.643 | 3.946 | 6.203 |
| Resolution | —— | 6.032 | 2.332 | 22.725 | |
| Peak area | 51.373 | 965.891 | 14.979 | 56.512 | |
| Tailing factor | 1.545 | 0.962 | 0.947 | 1.585 | |
| Number of theoretical plates | 4788.073 | 11795.839 | 15771.493 | 116968.328 | |
| 30min | Rt (min) | 2.756 | 3.643 | 3.946 | 6.208 |
| Resolution | —— | 6.025 | 2.314 | 23.045 | |
| Peak area | 56.805 | 936.573 | 19.543 | 34.205 | |
| Tailing factor | 1.544 | 0.929 | 1.021 | 1.594 | |
| Number of theoretical plates | 4789.232 | 11711.901 | 15593.435 | 126957.442 | |
| 45min | Rt (min) | 2.757 | 3.644 | 3.947 | 6.212 |
| Resolution | —— | 6.036 | 2.326 | 23.145 | |
| Peak area | 62.264 | 929.488 | 26.532 | 23.802 | |
| Tailing factor | 1.569 | 0.989 | 1.027 | 1.701 | |
| Number of theoretical plates | 4790.395 | 11793.688 | 15744.882 | 127107.633 | |
| Injection times | Peak area | ||||
|---|---|---|---|---|---|
| Methanol | Acetone | Tert butanol | Ethyl acetate | Triethylamine | |
| 1 | 308.7 | 2277.3 | 1422.6 | 1826.5 | 7043.8 |
| 2 | 313.5 | 2330.6 | 1439.6 | 1865.4 | 7199.6 |
| 3 | 311.6 | 2312.1 | 1439.6 | 1851.9 | 7079.7 |
| 4 | 317.5 | 2352.2 | 1463.2 | 1885 | 7354.7 |
| 5 | 319.7 | 2370.5 | 1487.3 | 1907.6 | 7395 |
| 6 | 329.9 | 2330.5 | 1511.1 | 1875.3 | 7026.9 |
| Average | 316.8 | 2328.9 | 1460.6 | 1868.6 | 7183.2 |
| RSD% | 2.38 | 1.39 | 2.29 | 1.49 | 2.24 |
| Residue solvent | Regression equations | R | Linearity range (mg/ml) |
|---|---|---|---|
| Methanol | Y = 981.35X + 10.04 | 0.9993 | 0.06-0.3 |
| Acetone | Y = 4517.4X + 78.569 | 0.9991 | 0.1-0.5 |
| Tert butanol | Y = 2756.5X + 45.711 | 0.9990 | 0.1-0.5 |
| Ethyl acetate | Y = 3507.5X + 56.446 | 0.9990 | 0.1-0.5 |
| Triethylamine | Y = 14349X + 252.25 | 0.9990 | 0.1-0.5 |
| Residue solvents | Theoretical concentration (mg/ml) |
Actual concentration (mg/ml) | Recovery (%) | Average recovery (%) | RSD (%) |
|---|---|---|---|---|---|
| Methanol | 0.18 | 0.1808 | 100.4 | 100.6 | 3.45 |
| 0.18 | 0.1803 | 100.2 | |||
| 0.18 | 0.1773 | 98.5 | |||
| 0.24 | 0.2336 | 97.3 | |||
| 0.24 | 0.2410 | 100.4 | |||
| 0.24 | 0.2409 | 100.4 | |||
| 0.3 | 0.2974 | 99.1 | |||
| 0.3 | 0.2983 | 99.4 | |||
| 0.3 | 0.3282 | 109.4 | |||
| Acetone | 0.3 | 0.3004 | 100.1 | 98.2 | 2.60 |
| 0.3 | 0.2990 | 99.7 | |||
| 0.3 | 0.2894 | 96.5 | |||
| 0.4 | 0.3779 | 94.5 | |||
| 0.4 | 0.3962 | 99.1 | |||
| 0.4 | 0.3890 | 97.2 | |||
| 0.5 | 0.4746 | 94.9 | |||
| 0.5 | 0.4966 | 99.3 | |||
| 0.5 | 0.5107 | 101.8 | |||
| Tert butanol | 0.3 | 0.3205 | 106.8 | 106.0 | 3.28 |
| 0.3 | 0.3185 | 106.2 | |||
| 0.3 | 0.3096 | 103.2 | |||
| 0.4 | 0.4074 | 101.9 | |||
| 0.4 | 0.4251 | 106.3 | |||
| 0.4 | 0.4270 | 106.7 | |||
| 0.5 | 0.5163 | 103.3 | |||
| 0.5 | 0.5284 | 105.7 | |||
| 0.5 | 0.5695 | 113.9 | |||
| Ethyl acetate | 0.3 | 0.3027 | 100.9 | 98.8 | 2.72 |
| 0.3 | 0.3005 | 100.2 | |||
| 0.3 | 0.2897 | 96.6 | |||
| 0.4 | 0.3804 | 95.1 | |||
| 0.4 | 0.3991 | 99.8 | |||
| 0.4 | 0.3946 | 98.6 | |||
| 0.5 | 0.4762 | 95.2 | |||
| 0.5 | 0.5002 | 100.0 | |||
| 0.5 | 0.5152 | 103.0 | |||
| Triethylamine | 0.3 | 0.2939 | 98.0 | 92.9 | 3.80 |
| 0.3 | 0.2922 | 97.4 | |||
| 0.3 | 0.2744 | 91.5 | |||
| 0.4 | 0.3527 | 88.2 | |||
| 0.4 | 0.3733 | 93.3 | |||
| 0.4 | 0.3572 | 89.3 | |||
| 0.5 | 0.4485 | 89.7 | |||
| 0.5 | 0.4755 | 95.1 | |||
| 0.5 | 0.4694 | 93.9 |
| Residue solvents | Conditions | |||
|---|---|---|---|---|
| 0.9ml/min | 1.0 ml/min | 1.1ml/min | 90℃ | |
| Acetone | 0.2068 | 0.2036 | 0.1999 | 0.1999 |
| Tert butanol | 0.0026 | 0.0024 | 0.0024 | 0.0024 |
| Triethylamine | 0.0056 | 0.0057 | 0.0043 | 0.0043 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).